| Jennifer Bell Smith, MA, CCC-SLP | |
|
7500 Bircklan Dr, Canton, MI 48187-1021 | |
| (734) 968-9280 | |
| Not Available |
| Full Name | Jennifer Bell Smith |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7500 Bircklan Dr, Canton, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588037287 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 7101000685 (Michigan) | Primary |
| Provider Name | Dearborn Speech And Sensory Center, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1033510821 PECOS PAC ID: 6901128487 Enrollment ID: O20141212000226 |
News Archive
A UK study supports a role for interhemispheric disconnectivity in bipolar disorder, showing reduced corpus callosum area and thickness in patients with the condition.
Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.
Lilly has already developed a protein called GDNF (glial cell line derived neurotrophic factor) known to preserve the function of neurons and Medtronic will provide a system that carries the medicine to a key area of the brain.
Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.
› Verified 3 days ago
| Provider Name | Behavioral Outcomes Management,llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1184139131 PECOS PAC ID: 1355602426 Enrollment ID: O20180306002107 |
News Archive
A UK study supports a role for interhemispheric disconnectivity in bipolar disorder, showing reduced corpus callosum area and thickness in patients with the condition.
Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.
Lilly has already developed a protein called GDNF (glial cell line derived neurotrophic factor) known to preserve the function of neurons and Medtronic will provide a system that carries the medicine to a key area of the brain.
Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Bell Smith, MA, CCC-SLP 7500 Bircklan Dr, Canton, MI 48187-1021 Ph: (734) 968-9280 | Jennifer Bell Smith, MA, CCC-SLP 7500 Bircklan Dr, Canton, MI 48187-1021 Ph: (734) 968-9280 |
News Archive
A UK study supports a role for interhemispheric disconnectivity in bipolar disorder, showing reduced corpus callosum area and thickness in patients with the condition.
Adaptive Sound Technologies, Inc. (ASTI) announced today that the Stanford University Medical Center has purchased Ecotones Duet Adaptive Sleep Sound Machines. "It is well known that noise in hospitals affects patient comfort and recovery, as well as staff performance. ASTI's adaptive technology can help with these problems," stated Sam Nicolino, President and CEO of ASTI.
Lilly has already developed a protein called GDNF (glial cell line derived neurotrophic factor) known to preserve the function of neurons and Medtronic will provide a system that carries the medicine to a key area of the brain.
Solvay has re-evaluated the commercial potential of bifeprunox, a Solvay compound in clinical development for the treatment of schizophrenia . Bifeprunox additionally has the potential to be developed in other disorders, i.e. bipolar disorder.
› Verified 3 days ago
North 42 Degrees Therapy Pllc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 42842 Lombardy Dr, Canton, MI 48187 Phone: 734-361-9804 Fax: 734-353-4300 | |
Lauren O'toole, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 5969 N Canton Center Rd, Canton, MI 48187 Phone: 877-407-3422 Fax: 877-407-4329 | |
Meredith Friend, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44560 Ford Rd, Canton, MI 48187 Phone: 734-680-8780 | |
Callie Waldrep, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44560 Ford Rd, Canton, MI 48187 Phone: 734-680-8780 | |
Patricia Dimaria, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45707 Morningside Dr, Canton, MI 48187 Phone: 734-391-9668 | |
Megan Kasper, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6879 Kings Mill Dr, Canton, MI 48187 Phone: 419-215-1324 | |
Nicole Quirk, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45570 Maben Rd, Canton, MI 48187 Phone: 313-999-1667 |